But what it does have is its critical role—albeit underrated—as a biotech hub. Competing with South San Francisco and Boston, ...

Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s ...

Lexicon Pharmaceuticals and Bristol-Myers Squibb, though both in pharma, are leagues apart in scale, profitability, and risk.

Bristol-Myers Squibb finds itself in the billionaire investors’ bargain bin, but with some surprisingly luxe packaging. The ...

However, there have been pacifying voices too. “It needs to be said: AI can’t fully replace human code review,” began Greg ...

Pathios Therapeutics Limited ("Pathios"), a biotech company focused on the development of first-in-class therapies for cancer, today announced the appointment of Sumeet Ambarkhane, M.D., as Chief ...

With a slew of tech announcements dominating the headlines recently, it’s been easy to overlook some equally important ...